Modulation of the powder properties of lamotrigine by crystal forms

Oisín N. Kavanagh; Chenguang Wang; Gavin M. Walker; Changquan Calvin Sun

doi:10.1016/j.ijpharm.2021.120274

Modulation of the powder properties of lamotrigine by crystal forms

Oisín N. Kavanagh, Chenguang Wang, Gavin M. Walker, Changquan Calvin Sun

Pharmaceutics

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Abstract

The mechanical properties of powders determine the ease of manufacture and ultimately the quality of the oral solid dosage forms. Although poor mechanical properties of an active pharmaceutical ingredient (API) can be mitigated by using suitable excipients in a formulation, the effectiveness of that approach is limited for high dose drugs or multidrug tablets. In this context, improving the mechanical properties of the APIs through solid form optimisation is a good strategy to address such a challenge. This work explores the powder and tableting properties of various lamotrigine (LAM) solid forms with the aim to facilitate direct compression by overcoming the poor tabletability of LAM. The two drug-drug crystals of LAM with nicotinamide and valproic acid demonstrate superior flowability and tabletability over LAM. The improved powder properties are rationalised by structure analysis using energy framework, scanning electron microscopy, and Heckel analysis.

Original language	English (US)
Article number	120274
Journal	International journal of pharmaceutics
Volume	595
DOIs	https://doi.org/10.1016/j.ijpharm.2021.120274
State	Published - Feb 15 2021

Bibliographical note

Funding Information:
OK wishes to thank the Irish Fulbright Commission for their support to facilitate this collaboration and Fiona Hogan and Caoimhe Murphy for their help in obtaining preliminary data and for stimulating discussions. This publication was also supported by a research grant from Science Foundation Ireland (12/RC/2275/2). 12/RC/2275/2 is co-funded under the European Regional Development Fund. We acknowledge the Minnesota Supercomputing Institute (MSI) at the University of Minnesota for providing resources that contributed to the research results reported within this paper. URL: http://www.msi.umn.edu.

Funding Information:
O.K. was responsible for the conceptualisation, methodology, investigation, visualisation. C.W. and C.C. Sun preformed the energy framework analysis. G.W. acquired financial support to enable the work and supervised the project. All authors discussed the results and contributed to the writing, reviewing and editing of the data within the manuscript.

Publisher Copyright:
© 2021 The Author(s)

Keywords

Cocrystal
Crystal engineering
Direct compaction
High drug load
Multidrug
Solid form optimisation
Tableting

Access

10.1016/j.ijpharm.2021.120274

OpenUrl availability

Full text

Cite this

@article{3994b6bce36e4d1db2761750148e1b4d,

title = "Modulation of the powder properties of lamotrigine by crystal forms",

abstract = "The mechanical properties of powders determine the ease of manufacture and ultimately the quality of the oral solid dosage forms. Although poor mechanical properties of an active pharmaceutical ingredient (API) can be mitigated by using suitable excipients in a formulation, the effectiveness of that approach is limited for high dose drugs or multidrug tablets. In this context, improving the mechanical properties of the APIs through solid form optimisation is a good strategy to address such a challenge. This work explores the powder and tableting properties of various lamotrigine (LAM) solid forms with the aim to facilitate direct compression by overcoming the poor tabletability of LAM. The two drug-drug crystals of LAM with nicotinamide and valproic acid demonstrate superior flowability and tabletability over LAM. The improved powder properties are rationalised by structure analysis using energy framework, scanning electron microscopy, and Heckel analysis.",

keywords = "Cocrystal, Crystal engineering, Direct compaction, High drug load, Multidrug, Solid form optimisation, Tableting",

author = "Kavanagh, {Ois{\'i}n N.} and Chenguang Wang and Walker, {Gavin M.} and Sun, {Changquan Calvin}",

note = "Funding Information: OK wishes to thank the Irish Fulbright Commission for their support to facilitate this collaboration and Fiona Hogan and Caoimhe Murphy for their help in obtaining preliminary data and for stimulating discussions. This publication was also supported by a research grant from Science Foundation Ireland (12/RC/2275/2). 12/RC/2275/2 is co-funded under the European Regional Development Fund. We acknowledge the Minnesota Supercomputing Institute (MSI) at the University of Minnesota for providing resources that contributed to the research results reported within this paper. URL: http://www.msi.umn.edu. Funding Information: O.K. was responsible for the conceptualisation, methodology, investigation, visualisation. C.W. and C.C. Sun preformed the energy framework analysis. G.W. acquired financial support to enable the work and supervised the project. All authors discussed the results and contributed to the writing, reviewing and editing of the data within the manuscript. Publisher Copyright: {\textcopyright} 2021 The Author(s)",

year = "2021",

month = feb,

day = "15",

doi = "10.1016/j.ijpharm.2021.120274",

language = "English (US)",

volume = "595",

journal = "International journal of pharmaceutics",

issn = "0378-5173",

publisher = "Elsevier",

}

TY - JOUR

T1 - Modulation of the powder properties of lamotrigine by crystal forms

AU - Kavanagh, Oisín N.

AU - Wang, Chenguang

AU - Walker, Gavin M.

AU - Sun, Changquan Calvin

N1 - Funding Information: OK wishes to thank the Irish Fulbright Commission for their support to facilitate this collaboration and Fiona Hogan and Caoimhe Murphy for their help in obtaining preliminary data and for stimulating discussions. This publication was also supported by a research grant from Science Foundation Ireland (12/RC/2275/2). 12/RC/2275/2 is co-funded under the European Regional Development Fund. We acknowledge the Minnesota Supercomputing Institute (MSI) at the University of Minnesota for providing resources that contributed to the research results reported within this paper. URL: http://www.msi.umn.edu. Funding Information: O.K. was responsible for the conceptualisation, methodology, investigation, visualisation. C.W. and C.C. Sun preformed the energy framework analysis. G.W. acquired financial support to enable the work and supervised the project. All authors discussed the results and contributed to the writing, reviewing and editing of the data within the manuscript. Publisher Copyright: © 2021 The Author(s)

PY - 2021/2/15

Y1 - 2021/2/15

N2 - The mechanical properties of powders determine the ease of manufacture and ultimately the quality of the oral solid dosage forms. Although poor mechanical properties of an active pharmaceutical ingredient (API) can be mitigated by using suitable excipients in a formulation, the effectiveness of that approach is limited for high dose drugs or multidrug tablets. In this context, improving the mechanical properties of the APIs through solid form optimisation is a good strategy to address such a challenge. This work explores the powder and tableting properties of various lamotrigine (LAM) solid forms with the aim to facilitate direct compression by overcoming the poor tabletability of LAM. The two drug-drug crystals of LAM with nicotinamide and valproic acid demonstrate superior flowability and tabletability over LAM. The improved powder properties are rationalised by structure analysis using energy framework, scanning electron microscopy, and Heckel analysis.

AB - The mechanical properties of powders determine the ease of manufacture and ultimately the quality of the oral solid dosage forms. Although poor mechanical properties of an active pharmaceutical ingredient (API) can be mitigated by using suitable excipients in a formulation, the effectiveness of that approach is limited for high dose drugs or multidrug tablets. In this context, improving the mechanical properties of the APIs through solid form optimisation is a good strategy to address such a challenge. This work explores the powder and tableting properties of various lamotrigine (LAM) solid forms with the aim to facilitate direct compression by overcoming the poor tabletability of LAM. The two drug-drug crystals of LAM with nicotinamide and valproic acid demonstrate superior flowability and tabletability over LAM. The improved powder properties are rationalised by structure analysis using energy framework, scanning electron microscopy, and Heckel analysis.

KW - Cocrystal

KW - Crystal engineering

KW - Direct compaction

KW - High drug load

KW - Multidrug

KW - Solid form optimisation

KW - Tableting

UR - http://www.scopus.com/inward/record.url?scp=85099827876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85099827876&partnerID=8YFLogxK

U2 - 10.1016/j.ijpharm.2021.120274

DO - 10.1016/j.ijpharm.2021.120274

M3 - Article

C2 - 33486026

AN - SCOPUS:85099827876

SN - 0378-5173

VL - 595

JO - International journal of pharmaceutics

JF - International journal of pharmaceutics

M1 - 120274

ER -

Modulation of the powder properties of lamotrigine by crystal forms

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this